A culture of safety and respect in sites of health care education and work is foundational to the well-being of everyone in health care.

Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.

Restraint can facilitate freedom for patients with traumatic brain injuries under some conditions.

Allocating resources for interventions requires consensus among stakeholders with a plurality of perspectives about how to weigh antimicrobial stewardship interventions’ risks and benefits.

Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks.

A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.

Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness.

Dr Donna-Bea Tillman joins Ethics Talk to discuss her article: "What Should the Public Know About Implantable Material and Device Innovation in the US?"